Clinical Study of Isosorbide on Meniere's Disease

DOI
  • KITAHARA Masaaki
    Department of Otorhinolaryngology, Shiga University of Medical Science
  • WATANABE Isamu
    Department of Otolaryngology, Tokyo Medical and Dental University, School of Medicine
  • HINOKI Manabi
    Shimane Medical University
  • MIZUKOSHI Kanemasa
    Department of Otolaryngology, Faculty of Medicine, Toyama Medical and Pharmaceutical University
  • MATSUNAGA Toru
    Department of Otorhinolaryngology, Osaka University, School of Medicine
  • MATSUNAGA Takashi
    Department of Otorhinolaryngology, Nara Medical College
  • KOMATSUZAKI Atsushi
    Department of Otorhinolaryngology, School of Medicine, Toho University
  • MATSUOKA IZURU
    Department of Otorhinolaryngology, Eaculty of Medicine, Kyoto University
  • UEMURA Takuya
    Department of Otorhinolaryngology, Faculty of Medicine, Kyushu University
  • MORIMITSU Tamotsu
    Department of Otorhinolaryngology, Miyazaki Medical College
  • ISHII Tetsuo
    Department of Otorhinolaryngology, Tokyo Women's Medical College
  • KUMOI Takeo
    Department of Otorhinolaryngology, Hyogo College of Medicine
  • SHIRABE Shigeaki
    Department of Otorhinolaryngology, School of Medicine, Fukuoka University
  • NAKAJIMA Shigeto
    Department of Otolaryngology, School of Medicine, Nagasaki University
  • FUTAKI Takashi
    Department of Otolaryngology, University of Tokyo
  • YAMAKAWA Munetaka
    Department of Otolaryngology, Hokkaido University, School of Medicine
  • KIKUCHI Naoko
    Department of Otorhinolaryngology, Tokyo Women's Medical College
  • INAMORI Toru
    Department of Otorhinolaryngology, Hyogo College of Medicine
  • OGINO Hitoshi
    Department of Otorhinolaryngology, Osaka University, School of Medicine
  • KAKIUCHI Hisami
    Department of Otorhinolaryngology, Nara Medical College
  • MAJIMA Kazuhiko
    Department of Otolaryngology, Tokyo Medical and Dental University, School of Medicine
  • OGAWA Nobuya
    Department of Pharmacology, Ehime University, School of Medicine

Bibliographic Information

Other Title
  • Isosorbideのメニエール病に対する効果に関する臨床的検討
  • Inter-group Comparative Study with Betahistine Mesylate by Multi-centered Double-blind Trial
  • 多施設二重盲検法によるBetahistine Mesylateとの群間比較

Abstract

Clinical effect of Isosorbide (ISO) was studied in patients with Meniere's disease from their subjective symptoms and objective findings by multi-centered double-blind trial with Betahistine Mesylate (BM) as a reference drug. 1) Global improvement rating: ISO-treated group was more superior than BM-treated group in 2 weeks and 4 weeks after administration with a statistically significant difference (P<0.05) in Wilcoxon test when statistical analysis was made based on the judgement by investigators, however, there was no statistically significant difference between both groups when analyzed based on the judgement by the Committee. 2) Utility rate: Upon the judgement by investigators, ISO-treated group was more superior than BM-treated group in 2 weeks and 4 weeks after administration with a tendency of statistical difference in Wilcoxon test, however, there was no statistically significant difference between both groups upon the judgement by the Committee. 3) Side effect, clinical laboratory test and safety rate: There was no particular difference between both groups. From the above results, it was concluded that ISO was an effective and useful drug for Meniere's disease.

Journal

  • OTOLOGIA FUKUOKA

    OTOLOGIA FUKUOKA 32 (1), 44-92, 1986-01-20

    JIBI TO RINSHO KAI

Keywords

Details 詳細情報について

  • CRID
    1390282680476098560
  • NII Article ID
    130004403124
  • DOI
    10.11334/jibi1954.32.1_44
  • ISSN
    04477227
  • Text Lang
    ja
  • Data Source
    • JaLC
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top